|
New York Press Releases
|
(EMAILWIRE.COM, April 18, 2012 ) New York, NY -- VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, provides a list of mid-week stocks to watch.
Included in the list are Immunocellular Therapeutics (IMUC), Synergy Pharmaceuticals (SGYP), Premier Alliance Group (PIMO), Capstone Turbine (CPST), BioDelivery Sciences (BDSI), Implant Sciences (IMSC) and Celsius Holdings (CELH), including others.
Shares of Immunocellular Therapeutics (IMUC) have been on the fly since the opening days of 2012, even having tripled at one point before settling down to a trading range of just below the three dollar mark.
With numerous catalysts still pending this year, including a possible move to the AMEX and the presentation of interim results for the ongoing ICT-107 trial - which could come as early as late 2012 - this is still a company and a stock to watch.
According to a PR from the company released a couple of months ago, full enrollment for the trial is expected to reached within the current quarter and an interim analysis will be conducted "when 50% of events (32 deaths) have been observed."
Additionally, last month an announcement hit the wires that Immunocellular had established a second manufacturing site for ICT-107, which allows the company to increase production and meet the demands of the compound for the ongoing Phase II trial, but also positions the company for success should ICT-107 make it to Phase III, which looks ever more likely with each update provided by the company.
Immunocellular, as well as other developing companies in the cancer immunotherapy field, could expect to receive a speculative boost around the time of the ASCO conference, as well, which this year is scheduled for June 1-5 in Chicago.
With such catalysts pending, it's likely that IMUC could withstand any effects of a broad market sell off, were one to develop, especially with the company's technology gaining notoriety in the field of cancer immunotherapy.
For full write-up visit: http://vfcsstockhouse.com/blog/article/-stocks-to-watch-mid-week-imuc-imsc-bdsi-cpst-pimo-sgyp-celh-dndn-hgsi-agen
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
About VFCsStockHouse.com:
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.
The goal of VFC's Stock House is to bring new ideas, companies and discussions to investors and readers. With respect to the increased amount of time necessary to maintain quality, VFC's Stock House is at times compensated from third parties to research and cover certain companies that fit the profile of what interests the readers of VFC's Stock House. While taking compensation poses as an inherent perception of bias in coverage, the ultimate goal is to bring ideas and information to the eyes of readers, who can then decide what is and what is not relevant.
For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
VFC
240-786-2111
vfc@vfcsstockhouse.com
|
|
|
|